Beispiel: Heart Attack

Klinische Studien gesponsert von Elixir Medical Corporation

Insgesamt 13 ergebnisse

NCT04562805

Rekrutierung

Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

Bedingungen: Coronary Artery Disease; Ischemic Heart Disease
NCT04375085

Rekrutierung

DESyne X2 Post Market Follow-up Study

Bedingungen: Coronary Artery Disease
NCT04192747

Rekrutierung

The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

Bedingungen: Coronary Artery Disease; Coronary Artery Stenosis; Coronary Disease; Coronary Stenosis
NCT04034121

Abgeschlossen

Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry

Bedingungen: Coronary Artery Disease
NCT03634020

Aktiv, nicht rekrutierend

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Bedingungen: Coronary Artery Disease
NCT03429894

Aktiv, nicht rekrutierend

Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study

Bedingungen: Coronary Artery Disease
NCT02869087

Aktiv, nicht rekrutierend

The DESappear Study: Drug Eluting Scaffold

Bedingungen: Peripheral Vascular Disease
NCT02453035

Beendet

DESolve® X-Pand Global Post Market Registry

Bedingungen: Coronary Artery Stenosis
NCT02086045

Abgeschlossen

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Bedingungen: Coronary Artery Disease
NCT02086006

Abgeschlossen

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Bedingungen: Coronary Artery Disease
NCT02013349

Abgeschlossen

DESolve Post-Approval Study

Bedingungen: Coronary Artery Disease
NCT02009956

Abgeschlossen

EXCELLA Post-Approval Study

Bedingungen: Coronary Artery Disease
NCT00792753

Abgeschlossen

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Bedingungen: Coronary Artery Disease